Xylem Inc.: 10-K Risk Factor Changes

2024 vs 2023  ·  SEC EDGAR  ·  2026-05-22
Other years: 2026 vs 2025 · 2025 vs 2024
⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

Xylem removed five pandemic and acquisition-related risks from its 2024 filing, reflecting the completion of the Evoqua acquisition and the receding nature of COVID-19 as an acute business threat. The company added two new risk disclosures focused on environmental liabilities from water treatment operations and project execution challenges, while substantively revising 14 existing risks with particular emphasis on geopolitical and supply chain vulnerabilities, operational disruptions, and economic headwinds.

✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

2
New Risks
5
Removed
14
Modified
10
Unchanged
🟢 New in Current Filing Water and wastewater treatment operations, including those related to emerging contaminants, as well as the generation, handling, storage, use, transport, treatment, release or disposal of hazardous materials may result in contamination, environmental, personal or other liabilities or pose other significant risks that could cause us to incur significant costs and reputational harm. 🔒
🟢 New in Current Filing If we are unable to successfully execute large projects or meet customers’ timelines, budget, performance and safety requirements, this could have a material adverse effect on our sales and profitability. 🔒
🔴 No Match in Current Filing We are unable to predict the extent to which the ongoing global COVID-19 pandemic, or other outbreaks, epidemics, pandemics, or public health crises may adversely impact our business, results of operations and financial condition. 🔒
🔴 No Match in Current Filing Our debt obligations may adversely affect our business and our ability to meet our obligations and pay dividends. 🔒
🔴 No Match in Current Filing Failure to complete our proposed acquisition of Evoqua could negatively impact our reputation, stock price and our future business and financial results. 🔒
🔴 No Match in Current Filing If our pending acquisition of Evoqua is consummated, our shareholders’ ownership percentage will be diluted, and the combined company’s earnings per share may decrease. 🔒
🔴 No Match in Current Filing The acquisition and integration of Evoqua may result in additional costs and expenses. 🔒
🟡 Modified Our business may be materially adversely affected by geopolitical, regulatory, economic, foreign exchange and other risks associated with our global sales, supply chain and operations. 🔒
🟡 Modified A material disruption to any of our facilities or operations, or that of third parties upon which we rely, may adversely affect our business and financial performance. 🔒
🟡 Modified Industry and economic conditions may adversely affect our markets and our customers’ operating conditions, which can in turn affect our business, results of operations and financial condition. 🔒
🟡 Modified Changes in our effective tax rates and tax expenses may adversely affect our financial results. 🔒
🟡 Modified Lack of or delay in availability of products, parts, raw materials and energy from our supply chain or the inability of suppliers to meet delivery and other requirements, could adversely affect our business. 🔒
🟡 Modified Failure to retain our existing leadership, engineering, technology, sales, services and other key talents or the inability to attract new qualified and diverse talent could negatively impact our business. 🔒
🟡 Modified Inflation, tariffs, customs duties and other increases in manufacturing and operating costs have, and could continue to, adversely affect our cash flows and results of operations. 🔒
🟡 Modified The execution of our strategy includes acquisitions and divestitures, which we may be unable to successfully execute. 🔒
🟡 Modified Defects, unanticipated or improper use or inadequate disclosures concerning our products could adversely affect our business, reputation and financial condition and results of operations. 🔒
🟡 Modified We may not realize some or all the expected benefits and synergies from our acquisition of Evoqua. 🔒
🟡 Modified Weather conditions, including the effects of climate change as well as associated efforts by governmental or regulatory authorities to mitigate such effects, may cause volatility in our served markets and affect our businesses, operations and financial results. 🔒
🟡 Modified Our financial results may fluctuate from period to period and can be difficult to predict. 🔒
🟡 Modified Cybersecurity incidents and related data breaches or other disruptions to our enterprise information technology and operations, or to our connected products and services, including those of third parties on which we or our customers rely, could materially and adversely affect our business. 🔒
🟡 Modified Failure to comply with, and the cost of complying with, laws, regulations, policies and taxes applicable to our operations, products and services, including those involving the environment, climate change, and health and safety, could have a material adverse impact on our business, results of operations, financial condition and reputation. 🔒
21 changes in this historical filing

Historical year-over-year comparisons (2024 vs 2023 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →